Recent Finacing
Recent Raise
Seraphina Therapeutics develops and commercializes FA15 (pentadecanoic acid, C15:0) as a vegan powdered ingredient and DTC subscription supplement (fatty15), holds patents and GRAS status, and runs randomized clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
